Your browser doesn't support javascript.
loading
Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel.
Shiota, Masaki; Nakamura, Motonobu; Yokomizo, Akira; Tomoda, Toshihisa; Sakamoto, Naotaka; Seki, Narihito; Hasegawa, Shuji; Yunoki, Takakazu; Harano, Masahiko; Kuroiwa, Kentaro; Eto, Masatoshi.
Afiliación
  • Shiota M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan shiota@uro.med.kyushu-u.ac.jp.
  • Nakamura M; Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Yokomizo A; Division of Urology, Harasanshin Hospital, Fukuoka, Japan.
  • Tomoda T; Department of Urology, Oita Prefectural Hospital, Oita, Japan.
  • Sakamoto N; Department of Urology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Seki N; Department of Urology, Kyushu Central Hospital, Fukuoka, Japan.
  • Hasegawa S; Department of Urology, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
  • Yunoki T; Department of Urology, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
  • Harano M; Department of Urology, JCHO Kyushu Hospital, Kitakyushu, Japan.
  • Kuroiwa K; Department of Urology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.
  • Eto M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Anticancer Res ; 40(1): 335-339, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31892584

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Androgénicos / Taxoides / Antagonistas de Receptores Androgénicos / Terapia Molecular Dirigida / Docetaxel Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Anticancer Res Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Grecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Androgénicos / Taxoides / Antagonistas de Receptores Androgénicos / Terapia Molecular Dirigida / Docetaxel Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male Idioma: En Revista: Anticancer Res Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Grecia